Condition
H1N1 2009 Influenza
Total Trials
1
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
1 treatments under study, led by Arepanrix Vaxigrip 20092010
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 1 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
100%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Phase 4 (1)
Trial Status
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (1)
Showing 1 of 1 trials
Showing all 1 trials
Research Network
Common Treatments
- Arepanrix Vaxigrip 200920101
Active Sponsors
- Canadian Institutes of Health Research (CIHR)1
- David Scheifele1
Top Investigators
University of Toronto, Mt Sinai Hospital
University of British Columbia
Institut national de sante publique du Quebec
McMaster University
Kingston, Frontenac, Lanark Health Unit
Related Conditions
- Influenza1